These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 33545873)

  • 1. Vitamin-B12-conjugated PLGA-PEG nanoparticles incorporating miR-532-3p induce mitochondrial damage by targeting apoptosis repressor with caspase recruitment domain (ARC) on CD320-overexpressed gastric cancer.
    Chen Z; Liang Y; Feng X; Liang Y; Shen G; Huang H; Chen Z; Yu J; Liu H; Lin T; Chen H; Wu D; Li G; Zhao B; Guo W; Hu Y
    Mater Sci Eng C Mater Biol Appl; 2021 Jan; 120():111722. PubMed ID: 33545873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin B12-conjugated sericin micelles for targeting CD320-overexpressed gastric cancer and reversing drug resistance.
    Guo W; Deng L; Chen Z; Chen Z; Yu J; Liu H; Li T; Lin T; Chen H; Zhao M; Zhang L; Li G; Hu Y
    Nanomedicine (Lond); 2019 Feb; 14(3):353-370. PubMed ID: 30328369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biodegradable hollow mesoporous organosilica nanotheranostics (HMON) for multi-mode imaging and mild photo-therapeutic-induced mitochondrial damage on gastric cancer.
    Guo W; Chen Z; Chen J; Feng X; Yang Y; Huang H; Liang Y; Shen G; Liang Y; Peng C; Li Y; Li G; Huang W; Zhao B; Hu Y
    J Nanobiotechnology; 2020 Jul; 18(1):99. PubMed ID: 32690085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Icaritin-loaded PLGA nanoparticles activate immunogenic cell death and facilitate tumor recruitment in mice with gastric cancer.
    Xiao Y; Yao W; Lin M; Huang W; Li B; Peng B; Ma Q; Zhou X; Liang M
    Drug Deliv; 2022 Dec; 29(1):1712-1725. PubMed ID: 35635307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strengthening Gastric Cancer Therapy by Trastuzumab-Conjugated Nanoparticles with Simultaneous Encapsulation of Anti-MiR-21 and 5-Fluorouridine.
    Hu N; Yin JF; Ji Z; Hong Y; Wu P; Bian B; Song Z; Li R; Liu Q; Wu F
    Cell Physiol Biochem; 2017; 44(6):2158-2173. PubMed ID: 29241186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondria-targeted cyclosporin A delivery system to treat myocardial ischemia reperfusion injury of rats.
    Zhang CX; Cheng Y; Liu DZ; Liu M; Cui H; Zhang BL; Mei QB; Zhou SY
    J Nanobiotechnology; 2019 Jan; 17(1):18. PubMed ID: 30683110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poly(D, L-lactide-co-glycolide) nanoparticles as delivery agents for photodynamic therapy: enhancing singlet oxygen release and photototoxicity by surface PEG coating.
    Boix-Garriga E; Acedo P; Casadó A; Villanueva A; Stockert JC; Cañete M; Mora M; Sagristá ML; Nonell S
    Nanotechnology; 2015 Sep; 26(36):365104. PubMed ID: 26293792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the synthesis of mucus permeating nanocarriers.
    Bourganis V; Karamanidou T; Samaridou E; Karidi K; Kammona O; Kiparissides C
    Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):239-49. PubMed ID: 25661586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of METase-pemetrexed-loaded PEG-PLGA nanoparticles modified with anti-CD133-scFV for treatment of gastric carcinoma.
    Xin L; Zhang HT; Yang WF; Li YF; Liu C
    Biosci Rep; 2018 Feb; 38(1):. PubMed ID: 29229675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of Oxidized Low Density Lipoprotein-Induced Endothelial Cell Injury by DA-PLGA-PEG-cRGD Nanoparticles Combined with Ultrasound.
    Li Z; Huang H; Huang L; Du L; Sun Y; Duan Y
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28406431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of Mir-34a in AGS Gastric Cancer Cells by a PLGA-PEG-PLGA Chrysin Nano Formulation.
    Mohammadian F; Abhari A; Dariushnejad H; Zarghami F; Nikanfar A; Pilehvar-Soltanahmadi Y; Zarghami N
    Asian Pac J Cancer Prev; 2015; 16(18):8259-63. PubMed ID: 26745070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Encapsulation in PLGA-PEG enhances 9- nitro-camptothecin cytotoxicity to human ovarian carcinoma cell line through apoptosis pathway.
    Ahmadi F; Derakhshandeh K; Jalalizadeh A; Mostafaie A; Hosseinzadeh L
    Res Pharm Sci; 2015; 10(2):161-8. PubMed ID: 26487893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exosomal transfer of miR-15b-3p enhances tumorigenesis and malignant transformation through the DYNLT1/Caspase-3/Caspase-9 signaling pathway in gastric cancer.
    Wei S; Peng L; Yang J; Sang H; Jin D; Li X; Chen M; Zhang W; Dang Y; Zhang G
    J Exp Clin Cancer Res; 2020 Feb; 39(1):32. PubMed ID: 32039741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-532-3p regulates mitochondrial fission through targeting apoptosis repressor with caspase recruitment domain in doxorubicin cardiotoxicity.
    Wang JX; Zhang XJ; Feng C; Sun T; Wang K; Wang Y; Zhou LY; Li PF
    Cell Death Dis; 2015 Mar; 6(3):e1677. PubMed ID: 25766316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation of Anti-miR-21 and 4-Hydroxytamoxifen Co-loaded Biodegradable Polymer Nanoparticles and Their Antiproliferative Effect on Breast Cancer Cells.
    Devulapally R; Sekar TV; Paulmurugan R
    Mol Pharm; 2015 Jun; 12(6):2080-92. PubMed ID: 25880495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulated microRNA-193a-3p is responsible for cisplatin resistance in CD44(+) gastric cancer cells.
    Lee SD; Yu D; Lee DY; Shin HS; Jo JH; Lee YC
    Cancer Sci; 2019 Feb; 110(2):662-673. PubMed ID: 30485589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Slippery Nanoparticles as a Diffusion Platform for Mucin Producing Gastrointestinal Tumors.
    Khalili M; Zhou H; Thadi A; Daniels L; Fan Z; Morano WF; Ang J; Goldstein E; Polyak B; Mapow BC; Cheng H; Bowne WB
    Ann Surg Oncol; 2020 Jan; 27(1):76-84. PubMed ID: 31187366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the liver targeting and anti‑liver cancer activity of artesunate‑loaded and glycyrrhetinic acid‑coated nanoparticles.
    Pan XW; Huang JS; Liu SR; Shao YD; Xi JJ; He RY; Shi TT; Zhuang RX; Bao JF
    Exp Ther Med; 2023 Nov; 26(5):516. PubMed ID: 37854499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile.
    Rafiei P; Haddadi A
    Int J Nanomedicine; 2017; 12():935-947. PubMed ID: 28184163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific cellular internalization and pH-responsive behavior of doxorubicin loaded PLGA-PEG nanoparticles targeted with anti EGFRvIII antibody.
    Eivazi N; Rahmani R; Paknejad M
    Life Sci; 2020 Nov; 261():118361. PubMed ID: 32861796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.